Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
25 June, 2018 18:53 IST
Zydus Cadila receives approval from USFDA for Fingolimod capsules
Source: IRIS | 17 Jul, 2017, 08.30AM
Comments  |  Post Comment

Zydus Cadila has received the tentative approval from the USFDA to market Fingolimod Capsules, 0.5 mg. The drug is an immunomodulating drug, mostly used for treating multiple sclerosis  and will be produced at the group’s formulations manufacturing facility at the Pharma SEZ, in Ahmedabad.

The sales of Fingolimod Capsules is estimated at USD 2.1 billionn. Source: IMS Health, IMS National Sales Perspective Audit, MAT May 2017, extracted July 2017.
 
The group now has more than 120 approvals and has so far filed over 300 ANDAs since the commencement of the filing process in FY 2003-04.  

Shares of the company gained Rs 13.9, or 2.68%, to settle at Rs 532.50. The total volume of shares traded was 152,487 at the BSE (Friday).





Cadila Healthcare Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
NHPC signs PPA with UPPCL for Kishanganga HE Project (3X110MW) project - 25-Jun-2018 16:47
Info Edge enters into agreement with Soft Bank for joint investment - 25-Jun-2018 16:43
Ratnamani Metals & Tubes receives order worth Rs 1.25 bn - 25-Jun-2018 16:38
Jet Airways to acquire 75 Boeing 737 MAX Aircrafts - 25-Jun-2018 16:35
MCX signs MoU with IMC to Synergise Efforts - 25-Jun-2018 16:16
Voltas JV lays ground to build 1st manufacturing unit - 25-Jun-2018 12:37
Vikas Ecotech to set up India's First 2-EHTG unit in Dahej - 25-Jun-2018 12:24
MBL Infra substantially completes two projects - 25-Jun-2018 12:19
Tata Comm partners with Singapore based IoT star-up W-Locate - 25-Jun-2018 10:26
DHFL expects 30% growth in home loan disbursements from Karnataka - 22-Jun-2018 11:22
KPIT, Kinetiq announce strategic life sciences collaboration - 22-Jun-2018 11:09
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer